Day: December 11, 2023

Ocean Power Technologies Secures a Multi-Buoy Letter Contract with a $6.5M Ceiling to Bolster Maritime Domain Awareness for US Government Agencies

Written by Customer Service on December 11, 2023. Posted in Public Companies.

MONROE TOWNSHIP, N.J., Dec. 11, 2023 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (“OPT” or “the Company”) (NYSE American: OPTT), a leader in innovative and cost-effective low-carbon marine power, data, and service solutions, today announced it has received a letter contract from a US based prime contractor for multiple maritime domain awareness buoys advancing our commitment to national security and intelligence. This collaboration between OPT and the prime contractor will focus on providing multidomain marine solutions in support of US government agencies. OPT’s PowerBuoy’s® will play a pivotal role in enhancing surveillance capabilities above and below the waterline, contributing significantly to maritime domain awareness initiatives. The current contract enables OPT to advance the preparation of...

Gorilla Technology Group Collaborates with Red Hat to Bring State-of-the-Art Cloud Infrastructure to Smart Government Security Convergence Solutions

Written by Customer Service on December 11, 2023. Posted in Public Companies.

LONDON, Dec. 11, 2023 (GLOBE NEWSWIRE) — Gorilla Technology Group Inc. (“Gorilla”) (NASDAQ: GRRR), a global provider of AI-based edge video analytics, IoT technologies, and security convergence, today announced its collaboration with Red Hat, the world’s leading provider of enterprise open-source solutions. Gorilla aims to revolutionize Smart Government Security Convergence solutions leveraging Red Hat OpenShift Virtualization, a feature of Red Hat OpenShift and Red Hat Enterprise Linux for cloud infrastructure deployment, operation, and management. As cyber threats evolve in complexity and frequency, governments worldwide face an ever-growing need for robust and agile solutions to maintain and manage their core networks. This collaboration brings together the innovation and expertise required to help address this need. “This...

Bel Fuse Announces Participation in the Oppenheimer Midwest Industrial (Virtual) Summit

Written by Customer Service on December 11, 2023. Posted in Public Companies.

WEST ORANGE, N.J., Dec. 11, 2023 (GLOBE NEWSWIRE) — Bel Fuse Inc. (Nasdaq: BELFA and BELFB), a designer, manufacturer, and provider of products that power, protect and connect electronic circuits, today announced plans to participate in the Oppenheimer (Virtual) Summit on December 13 -14. About Bel Bel (www.belfuse.com) designs, manufactures and markets a broad array of products that power, protect and connect electronic circuits. These products are primarily used in the networking, telecommunications, computing, military, aerospace, medical, transportation and broadcasting industries. Bel’s product groups include Magnetic Solutions (integrated connector modules, power transformers, power inductors and discrete components), Power Solutions and Protection (front-end, board-mount and industrial power products, module products...

High Wire Networks Reports Preliminary Third Quarter 2023 Results

Written by Customer Service on December 11, 2023. Posted in Earnings Releases And Operating Results.

Annualized Recurring Revenue at Record $15.6 Million, up 30% from Previous Quarter, Generated by Managed Cybersecurity and Tech Services Overwatch Managed Cybersecurity TCV up 53% Sequentially to Record $9.5 Million BATAVIA, Ill., Dec. 11, 2023 (GLOBE NEWSWIRE) — High Wire Networks, Inc. (OTCQB: HWNI), a leading global provider of managed cybersecurity and technology enablement, reported preliminary results for continuing operations for the three and nine months ended September 30, 2023. All comparisons are to the same year-ago period unless otherwise noted. The company plans to report its full official results for the third quarter and nine months following a restatement of its first and second quarter 2023 results which will remove a non-cash derivative liability. The restatements are anticipated to have a substantial...

Erasca Granted FDA Fast Track Designation for Pan-RAF Inhibitor Naporafenib in Patients with Advanced NRAS-Mutated Melanoma

Written by Customer Service on December 11, 2023. Posted in Public Companies.

First-in-class and best-in-class potential in NRAS-mutated melanoma and other RAS/MAPK pathway-altered solid tumors Naporafenib has been dosed in more than 500 patients to date, establishing its safety, tolerability, and preliminary proof-of-concept in multiple indications Pivotal Phase 3 SEACRAFT-2 trial initiation in NRAS-mutated melanoma on track for H1 2024 SAN DIEGO, Dec. 11, 2023 (GLOBE NEWSWIRE) — Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that the United States Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to naporafenib in combination with trametinib (MEKINIST®) for the treatment of adult patients with unresectable or...

DIRTT Announces Filing of Amended and Restated Rights Offering Circular

Written by Customer Service on December 11, 2023. Posted in Public Companies.

CALGARY, Alberta, Dec. 11, 2023 (GLOBE NEWSWIRE) — DIRTT Environmental Solutions Ltd. (“DIRTT” or the “Company”) (TSX: DRT; OTC: DRTTF), a leader in industrialized construction, announced today that it has filed an amended and restated rights offering notice and an amended and restated rights offering circular (collectively, the “Amended Documents“) in connection with the previously announced rights offering to its common shareholders for aggregate gross proceeds of C$30,000,000 (the “Rights Offering”). Pursuant to the terms of a standby purchase agreement dated November 20, 2023, two of DIRTT’s significant shareholders (the “Standby Purchasers“) have agreed to provide a standby commitment to fully backstop the Rights Offering. DIRTT has filed the Amended Documents to update the Standby Purchasers’...

Tarsus Announces Positive Topline Results from the Ersa Phase 2a Clinical Trial Evaluating TP-03 for the Treatment of Meibomian Gland Disease in Patients with Demodex Mites

Written by Customer Service on December 11, 2023. Posted in Public Companies.

TP-03 demonstrated statistically significant and clinically meaningful improvements across two objective measures of MGD, regardless of BID or TID dosing, and was well tolerated IRVINE, Calif., Dec. 11, 2023 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, today announced topline results from the Ersa Phase 2a clinical trial evaluating TP-03 (lotilaner ophthalmic solution, 0.25%) administered twice daily (BID) or three times a day (TID) for 12 weeks for the treatment of Meibomian Gland Disease (MGD) in patients with Demodex mites. In this study, TP-03 demonstrated statistically significant and clinically meaningful improvements compared to baseline in two objective measures of the disease...

Biora Therapeutics Announces New Research Collaboration for the BioJet™ Systemic Oral Delivery Platform

Written by Customer Service on December 11, 2023. Posted in Public Companies.

Pharma collaborator’s proprietary molecules will be tested with the BioJet platform in animal models SAN DIEGO, Dec. 11, 2023 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced a new research collaboration with a large pharmaceutical company for its BioJet™ Systemic Oral Delivery Platform. The new agreement provides funding to test the BioJet platform’s ability to achieve bioavailability through oral delivery of the undisclosed collaborator’s molecules to the small intestine in animal models. “This most recent deal shows that we are making great progress, and that progress is being recognized by others,” said Adi Mohanty, Chief Executive Officer of Biora Therapeutics. “We’re currently progressing two of our research collaboration studies...

Reviva to Participate in the Zacks Small-Cap Research Life Sciences Investor Forum

Written by Customer Service on December 11, 2023. Posted in Public Companies.

CUPERTINO, Calif., Dec. 11, 2023 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will participate live at the Life Sciences Investor Forum, hosted by VirtualInvestorConferences.com, on December 14th, 2023. Dr. Bhat will engage in a “CEO Chat” session with John Vandermosten, Senior Biotechnology Analyst with Zacks Small-Cap Research. The Life Sciences Investor Forum Date: Thursday, December 14, 2023 Time: 12 p.m. ET Location: Virtual Link: Click Here Available for 1×1 meetings: Thursday, December 14,...

Synchronoss Completes Cloud-Only Transformation, Reaffirms 2023 and 2024 Financial Projections

Written by Customer Service on December 11, 2023. Posted in Public Companies.

Emphasizing Expected Long-Term Financial Outlook and Strong Cash Flow Generation in 2024 and Beyond Identifies Significant Cost Savings for Immediate Positive Impact on Free Cash Flow BRIDGEWATER, N.J., Dec. 11, 2023 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (“Synchronoss” or the “Company”) (Nasdaq: SNCR), a leading global provider of personal cloud software and services, today provided the following updates enabled by the completion of its cloud-only transformation. In November, the Company announced the divestiture of its Messaging and NetworkX operations in conjunction with its Cloud-only business transformation. Post-transaction, management shared its initial expectation to improve the Company cost profile by eliminating approximately $10 million to $15 million of stranded and other costs from the standalone Cloud...

Day: December 11, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice